The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I Study with the Continual Reassessment Method for Dose Escalation of Weekly Paclitaxel in Combination with Carboplatin in Non-Small Cell Lung Cancer.
 
Yoshinori Kagawa
No Relationships to Disclose
 
Kohei Murata
No Relationships to Disclose
 
Atsushi Naito
No Relationships to Disclose
 
Kenji Kawai
No Relationships to Disclose
 
Yutaka Takeda
No Relationships to Disclose
 
Atsushi Takeno
No Relationships to Disclose
 
Toru Masuzawa
No Relationships to Disclose
 
Yoshiaki Ohmura
No Relationships to Disclose
 
Yoshiteru Katsura
No Relationships to Disclose
 
Kohei Murakami
No Relationships to Disclose
 
Takuya Sakamoto
No Relationships to Disclose
 
Ryota Mori
No Relationships to Disclose
 
Yohei Nose
No Relationships to Disclose
 
Keisuke Toya
No Relationships to Disclose
 
Yoshiro Yukawa
No Relationships to Disclose
 
Kouki Takase
No Relationships to Disclose
 
Takeshi Kato
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Takeda
Research Funding - Chugai Pharma
Expert Testimony - Lilly